CINECA IRIS Institutional Research Information System

SAPONARO, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 826
NA - Nord America 449
EU - Europa 158
SA - Sud America 139
AF - Africa 25
Totale 1.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 415
SG - Singapore 281
CN - Cina 195
VN - Vietnam 124
BR - Brasile 102
HK - Hong Kong 90
IT - Italia 39
JP - Giappone 34
GB - Regno Unito 29
IN - India 29
DE - Germania 21
FR - Francia 20
AR - Argentina 14
BD - Bangladesh 13
MX - Messico 13
IQ - Iraq 12
ZA - Sudafrica 11
FI - Finlandia 10
CA - Canada 9
NL - Olanda 9
EC - Ecuador 8
ID - Indonesia 6
PL - Polonia 6
TR - Turchia 6
PK - Pakistan 5
SE - Svezia 5
BB - Barbados 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CL - Cile 3
ES - Italia 3
MA - Marocco 3
RU - Federazione Russa 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
UZ - Uzbekistan 3
DO - Repubblica Dominicana 2
ET - Etiopia 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NG - Nigeria 2
PE - Perù 2
PS - Palestinian Territory 2
QA - Qatar 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BT - Bhutan 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
GY - Guiana 1
HN - Honduras 1
IE - Irlanda 1
JE - Jersey 1
JM - Giamaica 1
KG - Kirghizistan 1
LS - Lesotho 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
MZ - Mozambico 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
TH - Thailandia 1
TN - Tunisia 1
Totale 1.597
Salva come PNG Salva come JPEG
Città #
Singapore 132
San Jose 95
Hong Kong 90
Shanghai 62
Ho Chi Minh City 44
Los Angeles 38
Ashburn 33
Tokyo 33
Beijing 32
Hanoi 26
New York 19
Buffalo 12
Dallas 11
Denver 11
Florence 11
Chicago 10
Frankfurt am Main 9
Mexico City 9
Munich 9
Poplar 9
Redondo Beach 9
Santa Clara 9
Atlanta 8
Johannesburg 7
Mumbai 6
Orem 6
São Paulo 6
Turku 6
Baghdad 5
Montreal 5
Warsaw 5
Chandigarh 4
Da Nang 4
Haiphong 4
Leicester 4
L’Aquila 4
Thái Bình 4
Thái Nguyên 4
Amsterdam 3
Bexley 3
Biên Hòa 3
Chennai 3
Dhaka 3
Helsinki 3
Houston 3
Nashville 3
Phủ Lý 3
Porto Alegre 3
Quito 3
Quận Một 3
Rio de Janeiro 3
Stockholm 3
Tashkent 3
Addis Ababa 2
Almaty 2
Amman 2
Ankara 2
Aracaju 2
Bauru 2
Brasília 2
Bridgetown 2
Brooklyn 2
Bắc Giang 2
Bắc Ninh 2
Can Tho 2
Cape Town 2
Carapicuíba 2
Colombo 2
Dehradun 2
Des Moines 2
Doha 2
Erbil 2
Guayaquil 2
Ha Long 2
Hyderabad 2
Itapevi 2
Kansas City 2
Lucca 2
Maastricht 2
Miami 2
Milan 2
Mitry-Mory 2
Montevideo 2
Naples 2
Nha Trang 2
Paris 2
Port of Spain 2
Qingdao 2
Ribeirão das Neves 2
Salt Lake City 2
Santiago 2
Santo André 2
Santo Domingo 2
Seattle 2
St Louis 2
Sulaymaniyah 2
Sumaré 2
Tampa 2
Vitória da Conquista 2
Abu Dhabi 1
Totale 933
Salva come PNG Salva come JPEG
Nome #
Functional recovery of islet β cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches 91
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals 79
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease 66
Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery 65
HNF1A Deficiency Leads to Perturbed Glucagon Secretion in Humans 65
Impact of therapeutic doses of prednisolone and other glucocorticoids on insulin secretion from human islets 56
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis 56
Not all fats are created equal: adipose vs. ectopic fat, implication in cardiometabolic diseases 56
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms 54
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD 50
Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions 49
Genetic Modulation of HNF1A Activity via SGLT2 Deficiency Leads to Transient Intermittent Hyperglycemia: Consequences for HNF1A-MODY 49
Low-dose treatment with sulfonylureas improves hyperglucagonemia after a glucose challenge in HNF1A-MODY individuals and Hnf1a-/- mice 47
Aetiology and pathogenesis of HNF1A-MODY using human islets deficient of HNF1A and a new heterozygous mouse model (Hnf1aΔe4-10) of the human disease 44
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease 44
The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases 44
Cytocompatibility evaluation of glycol-chitosan coated boron nitride nanotubes in human endothelial cells 42
Where to for precision treatment of HNF1A-MODY? 40
Analysis of heterogeneity of individual donor and islet glucagon responses to glucose stimulated hormone secretion and drug therapy 39
Proglucagon-Derived Peptides Expression and Secretion in Rat Insulinoma INS-1 Cells 38
The role of the glucagon‐FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition 38
The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release 37
SGLT2 inhibition and glucagon secretion in humans 37
Analysis of Heterogeneity of Individual Donor and Islet Glucagon Responses to the SGLT2 Inhibitor Dapagliflozin 37
The central vs peripheral mediated effects of liraglutide enhancement on insulin secretion is dependent on the stage of diabetes 36
In non obese NAFLD increased plasma saturated fatty acids and insulin resistance are metabolic signatures of severity of liver disease 27
Inter-Individual Heterogeneity of SGLT2 Expression and Function in Human Pancreatic Islets 27
LIPIDOMICS REVEALS THAT LOW PLASMA UNSATURATED TO SATURATED FAT RATIOS ARE BIOMARKERS OF NAFLD AND LIVER DAMAGE 27
ADIPOSE TISSUE INSULIN RESISTANCE IS ASSOCIATED WITH MACROPHAGE ACTIVATION IN NON-DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 24
Standardized dynamic glucose testing reveals donor-dependent heterogeneity in human islet function 23
Recombinant PSP/reg treatment improves beta cell function in islets isolated from glucose intolerant and type 2 diabetic donors 23
Impact of glucocorticoids on islet function: role of SRD5A1 as a modulator of glucocorticoids bioavailability 23
Metabolic effects of sodium-glucose-co-transporter-4 (SGLT4) inhibition: from mouse studies to clinical translation 23
Correction to: Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease: Steatohepatitis/Metabolic Liver Disease (Hepatology, (2016), 63, 1, (107-116), 10.1002/hep.28287) 22
DEREGULATION OF DE NOVO LIPOGENESIS CAN BE ASSOCIATED WITH LIVER DAMAGE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 21
ANGIOPOIETIN-LIKE4 IS ASSOCIATED WITH LIPID METABOLISM AND SEVERE FIBROSIS IN NON-DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 21
Heterozygous HNF1A-MODY mice exhibit hyperglucagonemia preceding insulin secretory defects 20
GUT-LIVER AXIS DERANGEMENT DUE TO LACK OF INFLAMMASOME ACTIVITY LEADS TO VISCERAL OBESITY AND NASH DEVELOPMENT 19
Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile 18
Author Correction: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD (Scientific Reports, (2017), 7, 1, (12200), 10.1038/s41598-017-11744-6) 17
Adverse impact of visceral fat on lipid and metabolic profile in fatty liver disease 16
LIVER DAMAGE CAN BE ASSOCIATED WITH DEREGULATION OF THE DE NOVO LIPOGENESIS PATHWAY IN SUBJECTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 14
The Central-Versus Peripheral-Mediated Effects of Liraglutide Enhancement on Insulin Secretion is Dependent on the Stage of Diabetes 14
The GLP1R agonist liraglutide inhibits hyperglucagonaemia induced by the SGLT2 inhibitor dapagliflozin 13
Gut-liver axis derangement due to lack of inflammasome activity leads to visceral obesity and nash development 11
NKX6.1 mRNA copy number is an actionable biomarker associated with islet function and clinical outcomes after islet transplantation 1
Totale 1.663
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.277
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025438 0 0 0 0 0 0 0 116 31 42 49 200
2025/20261.225 19 122 54 191 219 102 140 122 111 94 51 0
Totale 1.663